Filings
Finds words inside filing documents. Searching Enliven Therapeutics, Inc.'s filings · 39 documents indexed.
7 documents · 93 matches
-
ELVN Enliven Therapeutics, Inc. 10-K 2026-03-03
Item 1A. Risk Factors.
tariffs, and we expect that the administration will continue with this practice. The introduction or imposition of new tariffs could15 matches in this document -
ELVN Enliven Therapeutics, Inc. 10-Q 2026-11-05
Item 1A. Risk Factors.
tariffs, any retaliatory actions in response thereto, taxes, and other limitations on cross-border operations, including but not limited to the provision13 matches in this document -
ELVN Enliven Therapeutics, Inc. 10-Q 2026-08-05
Item 1A. Risk Factors.
tariff on many imports from the European Union, with exceptions for generic medications and certain other items. While this 15% all-in tariff15 matches in this document -
ELVN Enliven Therapeutics, Inc. 10-Q 2026-05-07
Item 1A. Risk Factors.
tariffs preceding it, excludes certain items, as specified in Annexes to the President’s February 20, 2026 proclamation “Imposing a Temporary15 matches in this document -
ELVN Enliven Therapeutics, Inc. 10-Q 2025-11-12
Item 1A. Risk Factors.
tariffs could also negatively affect our ability to export and sell our potential products into those countries. If these tariffs12 matches in this document -
ELVN Enliven Therapeutics, Inc. 10-Q 2025-08-13
Item 1A. Risk Factors.
tariffs could also negatively affect our ability to export and sell our potential products into those countries. If these tariffs12 matches in this document -
ELVN Enliven Therapeutics, Inc. 10-Q 2025-05-14
Item 1A. Risk Factors.
including any trade restrictions or tariffs imposed by the United States or by other countries in response to U.S. tariffs; and11 matches in this document
Page 1 of 1 · 7 documents